Biomedical Engineering Reference
In-Depth Information
[48] Kajino T, Ohto C, Muramatsu M, Obata S, Udaka S, Yamada Y, Takahashi H. A protein
disulfide isomerase gene fusion expression system that increases the extracellular
productivity of Bacillus brevis. Appl Environ Microbiol 2000;66:638-642.
[49] Kurokawa Y, Yanagi H, Yura T. Overproduction of bacterial protein disulfide isomerase
(DsbC) and itsmodulator (DsbD) markedly enhances periplasmic production of human nerve
growth factor in Escherichia coli. J Biol Chem 2001;276:14393-14399.
[50] Zhan X, Schwaller M, Gilbert HF, Georgiou G. Facilitating the formation of disulfide bonds
in the Escherichia coli periplasm via coexpression of yeast protein disulfide isomerase.
Biotechnol Prog 1999;15:1033-1038.
[51] Zou L, Miles AP, Wang J, Stowers AW. Expression of malaria transmission-blocking vaccine
antigen Pfs25 in Pichia pastoris for use in human clinical trials. Vaccine 2003;21:1650-1657.
[52] Tsai CW, Duggan PF, ShimpRL Jr, Miller LH, NarumDL. Overproduction of Pichia pastoris
or Plasmodium falciparum protein disulfide isomerase affects expression, folding and
O-linked glycosylation of a malaria vaccine candidate expressed in P. pastoris.
J Biotechnol 2006;121:458-470.
